$2.16
-0.0201-0.92%
Last update: Nov 11, 6:44 AM

The average analyst price target for NOVONIX is $40, 1701.8% above the current price. The one analyst covering it rates it Buy. The latest change came on May 30, 2024, when Chardan Capital initiated coverage of NOVONIX with a Buy rating and a $40 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months